Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma
Fouad Choueiry(The Ohio State University), Lalit Sehgal(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 31
Related Papers
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
|Journal for ImmunoTherapy of Cancer|2020|99